Up a level |
Winston, Alan, Amin, Janaki, Clarke, Amanda, Else, Laura, Amara, Alieu ORCID: 0000-0002-1137-2948, Owen, Andrew ORCID: 0000-0002-9819-7651, Barber, Tristan, Jessen, Heiko, Avinghsanon, Anchalee, Chetchotisakd, Ploenchan et al (show 4 more authors)
(2015)
Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial.
CLINICAL INFECTIOUS DISEASES, 60 (7).
pp. 1026-1032.
Amara, Alieu B, Else, Laura J, Carey, Dianne, Khoo, Saye, Back, David J, Amin, Janaki, Emery, Sean and Puls, Rebekah L
(2017)
Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study.
THERAPEUTIC DRUG MONITORING, 39 (6).
654 - 658.
Amara, Alieu B ORCID: 0000-0002-1137-2948, Else, Laura J, Carey, Dianne, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David J, Amin, Janaki, Emery, Sean and Puls, Rebekah L
(2017)
Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study.
THERAPEUTIC DRUG MONITORING, 39 (6).
pp. 654-658.
Dickinson, Laura ORCID: 0000-0001-5557-9396, Amin, Janaki, Else, Laura, Boffito, Marta, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, Catherine, Clarke, Amanda et al (show 6 more authors)
(2016)
Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naive HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study.
CLINICAL PHARMACOKINETICS, 55 (7).
pp. 861-873.